Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-Cell lymphoma: A study of 37 previously untreated patients

Leukemia and Lymphoma

Volumn 28, Issue 3-4, 1998, Pages 295-306

  Romaguera, J E ^a   Rodriguez Diaz Pavon J ^a   Carias L ^a   Hagemeister, F B ^a   Mclaughlin, P ^a   Rodriguez M A ^a   Sarris, A H ^a   Younes, A ^a   Preti, A ^a   Bachier, C ^a   Llerena, E ^a   Cabanillas, F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Primary mediastinal lymphoma; Prognostic models

Indexed keywords

BETA 2 MICROGLOBULIN; DOXORUBICIN;

ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; HYPOTHESIS; MEDIASTINUM DISEASE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

EID: 6844258232     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809092685     Document Type: Article

References (33)

1. Liechtenstein, K., Levine, A., Taylor, C. R., Boswell, W., Rossman, S., Feinstein, D. I. and Lukes, R. J. (1980). Primary mediastinal lymphoma in adults. American Journal of Medicine, 68, 509-514.
2. Lamarre, L., Jacobson, J. O., Aisenberg, A. C. and Harris, N. L. (1989). Primary large cell lymphoma of the mediastinum: A histologic and immunophenotypic study of 29 cases. American Journal Surgical Pathology, 13(9), 730-739.
3. Perrone, T., Frizzera, G. and Rosai, J. (1986). Mediastinal diffuse large cell lymphoma with sclerosis: A clinicopathologic study of 60 cases. American Journal Surgical Pathology, 10(3), 176-191.
4. Miller, J. B., Variakojis, D., Bitran, J. D., Sweet, D. L., Kinzie, J. J., Golomb, H. M. and Ultmann, J. E. (1981). Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction. Cancer, 47, 748-756.
5. Addis, B. J. and Isaacson, P. G. (1985). Large cell lymphoma of the mediastinum: A B-cell tumor of probable thymic origin. Histopathology, 10, 379-390.
6. Möller, P., Moldenhauer, G., Momburg, F., Lammler, B., Erberlein-Gonska, M., Kiesel, S. and Dorken, B. (1987). Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B-cell differentiation. Blood, 69(4), 1087-1095.
7. Hofmann, W. J., Momburg, F., Möller, P. and Otto, H. F. (1988). Intra- and extrathymic B-cells in physiologic and pathologic conditions: Immunohistochemical study on normal thymus and lymphofollicular hyperplasia of the thymus. Virchows Archiv A Pathol Anat Histopathol, 412, 431-442.
8. Scarpa, A., Bonetti, F., Menestrina, F., Menegazzi, M., Chilosi, M., Lestani, M., Bovolenta, C., Zamboni, G. and Fiore-Donati, L. (1987). Mediastinal large cell lymphoma with sclerosis: Genotypic analysis establishes its B nature. Virchows Arch A, 412, 17-21.
9. Isaacson, P. G., Norton, A. J. and Addis, B. J. (1987). The human thymus contains a novel population of B-lymphocytes. Lancet, 1488-1490.
10. Joos, S., Otano-Joos, M., Ziegler, S., Brudelein, S., du Manoir, S., Bentz, M., Moller, P. and Lichter, P. (1996). Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood, 87(4), 1571-1578.
11. Jacobson, J. O., Aisenberg, A. C., Lamarre, L., Willet, C. G., Linggood, R. M., Miketic, L. M. and Harris, N. L. (1988). Mediastinal large cell lymphoma: An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer, 62, 1893-1898.
12. Todeschini, G., Ambrosetti, A., Meneghini, V., Pizzolo, G., Menestrina, F., Chilosi, M., Benedetti, F., Veneri, D., Cetto, G. L. and Perona, G. (1990). Mediastinal large B-cell lymphoma with sclerosis: A clinical study of 21 patients. Journal Clinical Oncology, 8(5), 804-808.
13. Al-Sharabati, M., Chittal, S., Duga-Neulat, I., Mazerolles, C. and Brousset, P. (1991). Primary anterior mediastinal B-cell lymphoma: A clinicopathologic study of 16 cases. Cancer, 647, 2579-2587.
14. Trump, D. I. and Mann, R. B. (1982). Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement: A poor prognostic subset of patients with non-Hodgkin's lymphomas. Cancer, 50, 277-282.
15. Bertini, M., Orsucci, L., Vitolo, U., Levis, A., Todeschini, G., Meneghini, V., Novero, D., Tarella, C., Gallo, E., Luxi, G., Pizzuti, M., Novarino, A., Urgesi, A. and Resegotti, L. (1991). Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Annals Oncology, 2, 733-737.
16. Kirn, D., Mauch, P., Shaffer, K., Pinkus, G., Shipp, M. A., Kaplan, W. D., Tung, N., Wheeler, C., Beard, C. J., Canellos, G. P. and Shulman, L. N. (1993). Large cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients. Journal Clinical Oncology, 11, 1336-1343.
17. The International Non-Hodgkin's Lymphoma Prognostic Factors Project ( 1993). A predictive model for aggressive non-Hodgkin's lymphomas. New England Journal Medicine, 329, 987-994.
18. Rodriguez, J., Cabanillas, F., McLaughlin, P., Swan, F., Rodriguez, M., Hagemeister, F. and Romaguera, J. (1992). A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the "tumor score." Annals Oncology, 3, 711-717.
19. Rodriguez, J., Pugh, W. C., Romaguera, J. E., Luthra, R., Hagemeister, F. B., McLaughlin, P., Rodriguez, M. A., Swan, F. and Cabanillas, F. (1994). Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low b2-microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase. Annals of Oncology, 5, 847-849.
20. Swan, F., Velasquez, W. S., Tucker, S., Redman, J. R., Rodriguez, M. A., McLaughlin, P., Hagemeister, F B. and Cabanillas, F. (1989). A new serologic staging system for large-cell lymphomas based on initial b2-microglobulin and lactate dehydrogenase levels. Journal Clinical Oncology, 7(10), 1518-1527.
21. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. C., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Muller-Hermellink, H. K., Pileri, S. A., Piris, M. A., Ralfkiaer, E. and Warnke, R. A. (1994). A revised european-american classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
22. Hsu, S. M., Raines, L. and Fanger, H. (1981). Use of avidinbiotin-peroxidase complex (ABC) and immunoperoxidase technique: Comparison between ABC and unlabeled antibody (PAP) procedures. Journal Histochemistry Cytochemistry, 29, 577-580.
23. Jagannath, S., Velasquez, W. S., Tucker, S. L., Fuller, L. M., McLaughlin, P. W., Manning, J. T., North, L. B. and Cabanillas, F. (1986). Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. Journal Clinical Oncology, 4, 859-865.
24. Rodriguez, V., Cabanillas, F., Burgess, M. A., McKelvey. E. M., Valdivieso, M. and Bodey, G. P. (1977). Combination chemotherapy "CHOP-Bleo" in advanced (non-Hodgkin) malignant lymphoma. Blood, 49, 325-333.
25. Cabanillas, F., McLaughlin, P., Hagemeister, F. B., Swan. F. Jr., Rodriguez, M. A., Romaguera, J., Majlis, A., Jendiroba, D. and Rodriguez, J. (1994). Improvement in survival and disease free survival of intermediate grade and immunoblastic lymphomas treated with the novel ATT regimen. Proceedings ASCO, 13, 338 (abstr.: 1323).
26. Velasquez, W., Hagemeister, F., Fuller, L. M., Allen, P. K., Tucker, S. I., Swan, F., Rodriguez, M. A., Hagemeister, F. B. and Cabanillas, F. (1994). Intermediate grade lymphomas treated with cyclophosphamide- doxorubicin-vincristine-prednisone and bleomycin (CHOP-Bleo) alternated with cyclophosphamide- methotrexate-etoposide-dexamethasone (CMED). Application of prognostic models to data analysis. Cancer, 73(9), 2408-2416.
27. Klimo, P. and Connors, J. M. (1985). MACOP-B Chemotherapy for the treatment of diffuse large-cell lymphoma. Annals of Internal Medicine, 102, 596-602.
28. Swan, F., Velasquez, W., Fuller, L., Rodriguez, A., MacLaughlin, P., Romaguera, J., Redman, J., Hagemeister, F., Cabanillas, F. (1991). Successful outcome of patients (pts) with good risk large cell lymphoma (LCL) with a shortened schedule of treatment (RX). Proc ASCO, 10, 273.
29. Peto. R. and Peto. J. (1972). Asymptotically efficient rank invariant test procedures. J R Stat Soc, 35, 185-207.
30. Kaplan, E. L. and Meier, P. (1958). Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
31. Cresswell, P., Springer, T. and Strominger, J. L. et al. (1974). Immunological identity of the small subunit of HLA antigens and beta 2-microglobulin and its turnover on the cell membrane. Proceedings of the National Academy Science of USA, 71, 2123-2127.
32. Fisher, R. I., Gaynor, E. R., Dahlberg, S., Martin, M. O., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A. Jr. and Miller, T. P. (1993). Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal Medicine. 328, 1002-1006.
33. Glick, G. H., Kine, K., Earle, J. and M. J. O'Connell (1995). An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL). Proceedings ASCO, 14, 391 (abstr 1221).